Monitor for actual sale execution in upcoming days; while the dollar amount is relatively small compared to ACET's $62M market cap, any insider-initiated selling in a microcap biotech could signal reduced conviction ahead of a catalyst or dilutive offering.
Price Chart
Executive Summary
OrbiMed Advisors Israel II Ltd, acting on behalf of fund OrbiMed Israel Partners II, L.P., filed a Form 144 to notify intent to sell up to 40,416 shares of Adicet Bio common stock. The sale would occur on or after the filing date of April 8, 2026, through the Nasdaq Stock Market.
Key Facts
- Reporting entity: OrbiMed Advisors Israel II Ltd (acting for OrbiMed Israel Partners II, L.P.)
- Subject company: Adicet Bio, Inc. (ACET)
- Number of shares proposed for sale: 40,416
- Share type: Common Stock
- Acquisition date: September 15, 2020, via merger
- Planned sale method: Open market or privately negotiated transaction via Themis Trading LLC
- Filing date: April 8, 2026
Financial Impact
Approximately $2.65 million based on current market price of $65.57 per share (40,416 shares × $65.57)
Risk Factors
- Potential downward pressure on stock price if sale is executed in a short timeframe
- Perception of negative sentiment from a long-standing institutional holder exiting part of its position
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000947871-26-000417 |
| Document: 0000947871-26-000417-index.html | 0000947871-26-000417 |
| Document: 0000947871-26-000417.txt | 0000947871-26-000417 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | SC 13G | $4.03 | awaiting T+20 | — | $3.99 (−0.98%) |
Sep 28, 2026 28d ago | 8-K | $6.35 $3.94 | ▼ −37.95% | ▼ −37.92% | $3.99 (−37.17%) |
Sep 1, 2026 7w ago | 8-K | $9.26 $7.12 | ▼ −23.11% | ▼ −24.29% | $3.99 (−56.91%) |
May 20, 2026 22w ago | 10-K/A | $7.89 $8.23 | ▲ +4.31% | ▲ +3.98% | $3.99 (−49.43%) |
May 13, 2026 23w ago | 8-K | $8.41 $8.05 | ▼ −4.28% | ▼ −3.42% | $3.99 (−52.56%) |
Apr 8, 2026 28w ago | 144 | $6.86 $8.55 | ▲ +24.64% | ▲ +17.07% | $3.99 (−41.84%) |
Apr 7, 2026 28w ago | 144 | $6.55 $8.51 | ▲ +29.92% | ▲ +21.38% | $3.99 (−39.08%) |
Mar 24, 2026 30w ago | EFFECT | $6.69 $8.31 | ▲ +24.22% | ▲ +15.31% | $3.99 (−40.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers